Abstract
Background: Single-modality treatment (surgery or radiotherapy [RT]) is a curative treatment option for early-stage oropharyngeal carcinoma (OPC) with comparable (excellent) oncological outcomes. This study aimed to compare self-reported swallowing function. Methods: Participants with a T1-2N0-2bM0 OPC who were offered single-modality treatment and were recruited to the Head and Neck 5000 study were included. Prospectively collected self-reported swallowing function was compared between surgery and RT. Results: Those offered RT (n = 150) had less favorable baseline characteristics than those offered surgery (n = 150). At 12-month follow up, RT participants reported more swallowing problems (35% vs 23%, RR 1.3; 95% CI 0.8-2.3, P =.277) in models adjusted for baseline characteristics. In those allocated to surgery who received adjuvant therapy (n = 78, 52%), the proportion with swallowing problems was similar to those allocated to RT alone. Conclusions: Participants offered surgery alone had similar mortality but improved swallowing, although this was not statistically significant. However, over half of participants offered surgery alone received surgery and adjuvant therapy.
Original language | English |
---|---|
Pages (from-to) | 1981-1993 |
Number of pages | 13 |
Journal | Head and Neck |
Volume | 42 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2020 |
Funding
This publication presents data from the HN5000 study that was a component of independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Scheme (RP-PG-0707-10034). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. Human papillomavirus (HPV) serology was supported by a Cancer Research UK Programme Grant, the Integrative Cancer Epidemiology Programme (grant number: C18281/A19169). The department of Head and Neck Oncology and Surgery of the Netherlands Cancer Institute receives a research grant from ATOS Medical to support this type of research. We thank Vanessa Marshall, Katrina Hurley, and Tom Stu for their contribution to the project.
Funders | Funder number |
---|---|
Integrative Cancer Epidemiology Programme | C18281/A19169 |
National Institute for Health Research | RP-PG-0707-10034 |
Cancer Research UK |